SPI-128 (Sound Pharmaceuticals)

N/A

Report date: 2024/12/26 17:05:34

Base Information

Drug NameSPI-128 (Sound Pharmaceuticals)
Drug Alias NameSPI-5505SPI-5557SPI-128
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionCyclin-dependent kinase inhibitor 1B inhibitors
TargetsCyclin-dependent kinase inhibitor 1B
Therapy Area/IndicationsHearing Loss, Sensorineural
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSound Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSound Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHearing Loss, Sensorineural

Other Information

ATC CodeN/A
Related LinksN/A